Comparative effectiveness of Paxlovid versus sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised patients: observational …

B Zheng, J Tazare, L Nab, A Mehrkar, B MacKenna… - medRxiv, 2023 - medrxiv.org
Objective To compare the effectiveness of Paxlovid vs. sotrovimab and molnupiravir in
preventing severe COVID-19 outcomes in non-hospitalised high-risk COVID-19 adult …
被引用次数：12 相关文章
[HTML] europepmc.org

[HTML][HTML] Comparative effectiveness of Paxlovid versus sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised patients …

B Zheng, J Tazare, L Nab, A Mehrkar, B MacKenna… - 2023 - europepmc.org
Objective To compare the effectiveness of Paxlovid vs. sotrovimab and molnupiravir in
preventing severe COVID-19 outcomes in non-hospitalised high-risk COVID-19 adult …
[PDF] archive.org

[PDF][PDF] Comparative effectiveness of Paxlovid versus sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised patients …

B Zheng, J Tazare, L Nab, A Mehrkar, B MacKenna… - scholar.archive.org
Objective: To compare the effectiveness of Paxlovid vs. sotrovimab and molnupiravir in
preventing severe COVID-19 outcomes in non-hospitalised high-risk COVID-19 adult …